Treatment (Tx) sequencing with tepotinib in previously treated patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION trial Meeting Abstract


Authors: Viteri, S.; Felip, E.; Griesinger, F.; Garassino, M. C.; Sakai, H.; Le, X.; Veillon, R.; Smit, E. F.; Raskin, J.; Thomas, M.; Ahn, M. J.; Vlassak, S.; Bruns, R.; Johne, A.; Paik, P. K.
Abstract Title: Treatment (Tx) sequencing with tepotinib in previously treated patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION trial
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S791
End Page: S792
Language: English
ACCESSION: WOS:001087480202057
PROVIDER: wos
DOI: 10.1016/j.annonc.2023.09.2413
Notes: Meeting Abstract: 1380P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    257 Paik